These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15523594)

  • 1. Lipid peroxidation at various estradiol concentrations in human circulation during ovarian stimulation with exogenous gonadotropins.
    Kaya H; Sezik M; Ozkaya O; Dittrich R; Siebzehnrubl E; Wildt L
    Horm Metab Res; 2004 Oct; 36(10):693-5. PubMed ID: 15523594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid peroxidation and vitamin E in serum and follicular fluid of infertile women with peritoneal endometriosis submitted to controlled ovarian hyperstimulation: a pilot study.
    Campos Petean C; Ferriani RA; dos Reis RM; de Moura MD; Jordão AA; Navarro PA
    Fertil Steril; 2008 Dec; 90(6):2080-5. PubMed ID: 18249400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF.
    Manau D; Fábregues F; Peñarrubia J; Creus M; Carmona F; Casals G; Jiménez W; Balasch J
    Hum Reprod; 2007 Mar; 22(3):669-75. PubMed ID: 17079244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.
    De Placido G; Alviggi C; Perino A; Strina I; Lisi F; Fasolino A; De Palo R; Ranieri A; Colacurci N; Mollo A;
    Hum Reprod; 2005 Feb; 20(2):390-6. PubMed ID: 15576390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphometric changes in the endometrium and serum leptin levels during the implantation period of the embryo in the rat in response to exogenous ovarian stimulation.
    Dursun A; Sendag F; Terek MC; Yilmaz H; Oztekin K; Baka M; Tanyalcin T
    Fertil Steril; 2004 Oct; 82 Suppl 3():1121-6. PubMed ID: 15474084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells.
    Cai J; Lou HY; Dong MY; Lu XE; Zhu YM; Gao HJ; Huang HF
    Fertil Steril; 2007 Jun; 87(6):1350-6. PubMed ID: 17296182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial.
    Tartagni M; Cicinelli E; De Pergola G; De Salvia MA; Lavopa C; Loverro G
    Fertil Steril; 2007 Apr; 87(4):858-61. PubMed ID: 17261285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-alpha (Gonal-F) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology.
    Moon SY; Choi YS; Ku SY; Kim SH; Choi YM; Kang IS; Kim CH
    J Obstet Gynaecol Res; 2007 Jun; 33(3):305-15. PubMed ID: 17578360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone.
    Foong SC; Abbott DH; Lesnick TG; Session DR; Walker DL; Dumesic DA
    Fertil Steril; 2005 May; 83(5):1377-83. PubMed ID: 15866572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH).
    Chen QJ; Sun XX; Li L; Gao XH; Wu Y; Gemzell-Danielsson K; Cheng LN
    Acta Obstet Gynecol Scand; 2007; 86(7):849-54. PubMed ID: 17611831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
    Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
    Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
    Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.
    Smitz J; Andersen AN; Devroey P; Arce JC;
    Hum Reprod; 2007 Mar; 22(3):676-87. PubMed ID: 17110397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian response to gonadotropin stimulation in juvenile rhesus monkeys.
    Yang S; He X; Niu Y; Hildebrandt TB; Jewgenow K; Goeritz F; Tang X; Chang Y; Zhou Q; Ji W
    Theriogenology; 2009 Jul; 72(2):243-50. PubMed ID: 19362733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum CA-125 and inhibin B levels in the prediction of ovarian response to gonadotropin stimulation in in vitro fertilization cycles.
    Urbancsek J; Hauzman EE; Murber A; Lagarde AR; Rabe T; Papp Z; Strowitzki T
    Gynecol Endocrinol; 2005 Jul; 21(1):38-44. PubMed ID: 16048800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of follicle wave emergence in cyclic ewes by supraphysiologic concentrations of estradiol-17beta and induction with a physiologic dose of exogenous ovine follicle-stimulating hormone.
    Barrett DM; Bartlewski PM; Duggavathi R; Davies KL; Rawlings NC
    Biol Reprod; 2006 Oct; 75(4):633-41. PubMed ID: 16837645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human follicle-stimulating hormone alters maternal ovarian hormone concentrations and the uterus and perturbs fetal development in mice.
    Kelley RL; Kind KL; Lane M; Robker RL; Thompson JG; Edwards LJ
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E761-70. PubMed ID: 16720629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.